| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/18/2003 | CA2478706A1 Oxo-azabicyclic compounds |
| 09/18/2003 | CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity |
| 09/18/2003 | CA2478684A1 Dispersed solid-containing complex carbohydrate |
| 09/18/2003 | CA2478599A1 Salts of nateglinide |
| 09/18/2003 | CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis |
| 09/18/2003 | CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate |
| 09/18/2003 | CA2478245A1 Treatment and prevention of inflammatory disorders |
| 09/18/2003 | CA2478107A1 Surgical device for skin therapy or testing |
| 09/18/2003 | CA2478065A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/18/2003 | CA2477329A1 Controlled delivery patch of active ingredient |
| 09/18/2003 | CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 09/18/2003 | CA2475738A1 Activated protein c formulations |
| 09/18/2003 | CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 09/17/2003 | EP1344529A1 Therapeutic compositions for treating male pattern baldness |
| 09/17/2003 | EP1344528A1 External skin preparations and process for producing the same |
| 09/17/2003 | EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 09/17/2003 | EP1343888A2 Regulation of human chemokine-like receptor |
| 09/17/2003 | EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases |
| 09/17/2003 | EP1343826A1 Polysaccharide compound having immune stimulating activity |
| 09/17/2003 | EP1343822A2 Means for the diagnosis and therapy of ctcl |
| 09/17/2003 | EP1343813A1 Novel compounds |
| 09/17/2003 | EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 09/17/2003 | EP1343784A2 Urea substituted imidazoquinoline ethers |
| 09/17/2003 | EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/17/2003 | EP1343775A2 Piperazine derivatives |
| 09/17/2003 | EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/17/2003 | EP1343769A1 Benzoylpyridazines |
| 09/17/2003 | EP1343764A1 Urea and urethane derivatives as integrin inhibitors |
| 09/17/2003 | EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
| 09/17/2003 | EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/17/2003 | EP1343561A1 Serine protease inhibitors |
| 09/17/2003 | EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 09/17/2003 | EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 09/17/2003 | EP1343505A1 Cxcr3 antagonists |
| 09/17/2003 | EP1343487A2 Methods and compositions to treat conditions associated with neovascularization |
| 09/17/2003 | EP1343486A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/17/2003 | EP1343485A2 Lipid-based nitric oxide donors |
| 09/17/2003 | EP1343470A2 Methods and compositions for protecting and restoring skin using selective mmp inhibitors |
| 09/17/2003 | EP1343467A1 Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a carotenoid |
| 09/17/2003 | EP1343465A2 Use of dna repair enzymes as mmp-1 inhibitors |
| 09/17/2003 | EP1343459A1 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least one isoflavonoid |
| 09/17/2003 | EP1196411B1 Bradykinin b1 receptor antagonists |
| 09/17/2003 | EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 09/17/2003 | EP1150655B1 Use of nanoscale chitosanes |
| 09/17/2003 | EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 09/17/2003 | EP1133471B1 Hydrazine derivatives |
| 09/17/2003 | EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 09/17/2003 | EP1095021B1 Quinoline derivatives |
| 09/17/2003 | EP1060242A4 Purified populations of stem cells |
| 09/17/2003 | EP0996446B1 Novel substituted imidazole compounds |
| 09/17/2003 | EP0975325B1 Compositions comprising a combination of a free sphingoid base and a ceramide and use thereof |
| 09/17/2003 | EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443199A Antibodies to human MCP-1 |
| 09/17/2003 | CN1443190A Matrix metalloproteinase inhibitors |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1443184A 嘧啶衍生物 Pyrimidine derivatives |
| 09/17/2003 | CN1443173A Substituted imidazoles as TAFI a inhibitors |
| 09/17/2003 | CN1443170A Capsaicin receptor ligands |
| 09/17/2003 | CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis |
| 09/17/2003 | CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors |
| 09/17/2003 | CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 09/17/2003 | CN1442194A External use medicine for treating burn and scald and its preparation method |
| 09/17/2003 | CN1442173A Medicine for treating burn scald and frostbite |
| 09/17/2003 | CN1442155A Lulusu synthetic medicinal liquid |
| 09/17/2003 | CN1442153A Ointment for moistening burn and scald and its making method |
| 09/17/2003 | CN1442151A Mackefulan immune liquid |
| 09/17/2003 | CN1442149A External use film forming powder for eliminating wound surface inflammation |
| 09/17/2003 | CN1442139A Medicinal composition for treating inflammation |
| 09/17/2003 | CN1442131A Medical bath natural seawater extract and its preparation method |
| 09/17/2003 | CN1121389C Cyanoguanidines as cell proliferation inhibitors |
| 09/17/2003 | CN1121235C Medicine for treating osteoporosis and its preparing process |
| 09/17/2003 | CN1121231C Mosquito repellent antipruritic liquid and its preparing process |
| 09/17/2003 | CN1121227C Veterinary medicine prepared from sophora seed and its preparing process |
| 09/17/2003 | CN1121222C Ointment for treating sweety feet and body odor and its preparation |
| 09/17/2003 | CN1121215C Amino acid derivatives and active oxygen resisting agent |
| 09/17/2003 | CN1121211C Detergent composition for skin |
| 09/17/2003 | CN1121209C Cosmetic compositions for photoprotection of skin and/or hair, based on synergistic mixture of screening agents, and uses thereof |
| 09/17/2003 | CN1121208C Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
| 09/17/2003 | CN1121200C Cosmetic composition for rejuvenation of skin without skin irratation |
| 09/16/2003 | US6620845 For therapy and prophylaxis of neurological diseases |
| 09/16/2003 | US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 09/16/2003 | US6620835 Method of inhibiting matrix metalloproteinases |
| 09/16/2003 | US6620832 Substituted ureas |
| 09/16/2003 | US6620803 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 09/16/2003 | US6620790 Stimulate hair growth |
| 09/16/2003 | US6620784 Uses of VEGF-E |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620420 Cosmetic or dermatological application |
| 09/16/2003 | US6620419 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 09/16/2003 | US6620407 Solid polymer particles having hydrophilic and lipophilic properties |
| 09/16/2003 | CA2309573C Antiperspirant suspensions containing finely divided aluminium and zirconium, having better effectiveness and a process for their manufacture |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2172493C Use of angiotensin iii and analogs thereof in tissue repair |
| 09/12/2003 | WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/12/2003 | WO2003074495A1 Hppars activators |
| 09/12/2003 | WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase |
| 09/12/2003 | WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments |
| 09/12/2003 | WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |